Latest news

InsightsJune 29, 2026

Top 10 Trends Reshaping Biotech R&D Infrastructure

Executive Summary Biotechnology research and development is undergoing one of the most significant infrastructure transformations in its history. For decades, biotech...

InsightsJune 29, 2026

The Rise of Multi-Omics in Drug Development

Executive Summary The pharmaceutical industry has always depended on a deeper understanding of human biology to drive therapeutic innovation. For decades,...

ClinicalJune 29, 2026

Ollin Brings in $330M to Advance Eye Disease Drug Through Phase 3 Trial

Six months after reporting early clinical data that outperformed Genentech’s blockbuster eye therapy Vabysmo, Ollin Biosciences has secured $330...

CommercialJune 29, 2026

BIO 2026: A Saudi sovereign wealth fund business and Flagship sign a research partnership

Flagship and Lean are looking to combine Lean's platform and ecosystem with Flagship's expertise in building and launching biopharmaceutical...

InsightsJune 29, 2026

The Coming Talent Crisis in Life Sciences

Executive Summary The life sciences industry is entering one of...

InsightsJune 29, 2026

How AI Is Changing the Economics of Drug Discovery

Executive Summary Drug discovery has long been one of the...

CommercialJune 29, 2026

Biogen Pens $1B Deal to Acquire RayThera, Bagging Preclinical Immunology Assets

Biogen has agreed to acquire RayThera in a deal valued at up to $1 billion, gaining access to a...

RegulatoryJune 28, 2026

FDA Expands Ionis’ Tryngolza Approval to Treat Severe Hypertriglyceridemia

The U.S. Food and Drug Administration (FDA) has approved a major label expansion for Ionis Pharmaceuticals' Tryngolza (olezarsen), allowing...

InsightsJune 28, 2026

Why Patient Recruitment Remains Pharma’s Most Expensive Bottleneck

Executive Summary Patient recruitment remains one of the most persistent and expensive bottlenecks in pharmaceutical development. Despite decades of investment in...

RegulatoryJune 28, 2026

EMA Committee Recommends Revoking EU Approval of Tavneos After Review of Supporting Trial Data

The European Medicines Agency’s Committee for Medicinal Products for...

ClinicalJune 28, 2026

Epicrispr Reports Increased Muscle Volume in Early-Stage FSHD Trial of EPI-321

Epicrispr Biotechnologies has reported interim results from an ongoing...

RegulatoryJune 26, 2026

FDA Cites Pinnacle Biologics Over Promotional Videos for Photofrin Cancer Therapy

The U.S. Food and Drug Administration (FDA) has issued an untitled letter to Pinnacle Biologics, stating that promotional videos...

InsightsJune 23, 2026

Top 10 AI Applications Transforming Pharmaceutical Market Access

Executive Summary Market access has become one of the most strategically important functions within the pharmaceutical industry. Securing regulatory approval...

InsightsJune 23, 2026

The Future of Scientific Engagement in an AI-Driven World

Executive Summary Scientific engagement is undergoing one of the most significant transformations in its history. For decades, scientific exchange in the...